GSK CEO: Big pharma should keep investing in R&D
May 02, 2016 at 18:38 PM EDT
GlaxoSmithKline CEO Andrew Whitty thinks his company's success has been a product of being patient and staying invested in innovation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.